Rita Horvath

Summary

Affiliation: University of Newcastle
Country: UK

Publications

  1. ncbi Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10)
    Rita Horvath
    Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK
    J Inherit Metab Dis 35:679-87. 2012
  2. ncbi A new phenotype of brain iron accumulation with dystonia, optic atrophy, and peripheral neuropathy
    Rita Horvath
    Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
    Mov Disord 27:789-93. 2012
  3. ncbi Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy
    Rita Horvath
    Mitochondrial Research Group, Institute for Ageing and Health, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK
    Brain 132:3165-74. 2009
  4. ncbi Adult-onset cerebellar ataxia due to mutations in CABC1/ADCK3
    Rita Horvath
    Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK
    J Neurol Neurosurg Psychiatry 83:174-8. 2012
  5. ncbi Heteroplasmic mutation in the anticodon-stem of mitochondrial tRNA(Val) causing MNGIE-like gastrointestinal dysmotility and cachexia
    Rita Horvath
    Friedrich Baur Institute, Department of Neurology, Ludwig Maximilians University, Ziemssenstr 1a, Munich 80336, Germany
    J Neurol 256:810-5. 2009
  6. ncbi What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr?
    Vivienne C M Neeve
    Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK
    Brain 135:3614-26. 2012
  7. ncbi Variation in MAPT is not a contributing factor to the incomplete penetrance in LHON
    Gavin Hudson
    Institute for Human Genetics, Newcastle University, Newcastle upon Tyne, UK
    Mitochondrion 11:620-2. 2011
  8. ncbi Late-onset ptosis and myopathy in a patient with a heterozygous insertion in POLG2
    Maggie C Walter
    Friedrich Baur Institute, Department of Neurology, Ludwig Maximilians University, Munich, Germany
    J Neurol 257:1517-23. 2010
  9. ncbi The pathogenic m.3243A>T mitochondrial DNA mutation is associated with a variable neurological phenotype
    Charlotte L Alston
    Institute for Ageing and Health, The Medical School, Newcastle University, Newcastle upon Tyne, UK
    Neuromuscul Disord 20:403-6. 2010
  10. ncbi POLG mutations cause decreased mitochondrial DNA repopulation rates following induced depletion in human fibroblasts
    Joanna D Stewart
    Mitochondrial Research Group, Institute of Human Genetics, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK
    Biochim Biophys Acta 1812:321-5. 2011

Detail Information

Publications37

  1. ncbi Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10)
    Rita Horvath
    Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK
    J Inherit Metab Dis 35:679-87. 2012
    ..CoQ(10) supplementation may be beneficial in both primary and secondary deficiencies and therefore the early recognition of these diseases is of utmost importance...
  2. ncbi A new phenotype of brain iron accumulation with dystonia, optic atrophy, and peripheral neuropathy
    Rita Horvath
    Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
    Mov Disord 27:789-93. 2012
    ..Neurodegeneration with brain iron accumulation is clinically and genetically heterogeneous because of mutations in at least 7 nuclear genes...
  3. ncbi Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy
    Rita Horvath
    Mitochondrial Research Group, Institute for Ageing and Health, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK
    Brain 132:3165-74. 2009
    ..This study provides the rationale for a simple genetic test to identify infants with mitochondrial myopathy and good prognosis...
  4. ncbi Adult-onset cerebellar ataxia due to mutations in CABC1/ADCK3
    Rita Horvath
    Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK
    J Neurol Neurosurg Psychiatry 83:174-8. 2012
    ..Inherited ataxias are heterogeneous disorders affecting both children and adults. The primary cause can be identified in about half of the patients and only very few can receive causative therapy...
  5. ncbi Heteroplasmic mutation in the anticodon-stem of mitochondrial tRNA(Val) causing MNGIE-like gastrointestinal dysmotility and cachexia
    Rita Horvath
    Friedrich Baur Institute, Department of Neurology, Ludwig Maximilians University, Ziemssenstr 1a, Munich 80336, Germany
    J Neurol 256:810-5. 2009
    ..Our finding adds to the genetic heterogeneity of MNGIE-like gastrointestinal symptoms and highlights the importance of a thorough genetic workup in case of suspected mitochondrial disease...
  6. ncbi What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr?
    Vivienne C M Neeve
    Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK
    Brain 135:3614-26. 2012
    ..Our results suggest that the mitochondrial DNA background plays an important role in modifying the disease phenotype but nuclear modifiers, epigenetic and environmental factors may also influence the severity of disease...
  7. ncbi Variation in MAPT is not a contributing factor to the incomplete penetrance in LHON
    Gavin Hudson
    Institute for Human Genetics, Newcastle University, Newcastle upon Tyne, UK
    Mitochondrion 11:620-2. 2011
    ..Our findings suggest that genetic variation in MAPT is unlikely to make a major contribution to the risk of blindness among LHON mutation carriers...
  8. ncbi Late-onset ptosis and myopathy in a patient with a heterozygous insertion in POLG2
    Maggie C Walter
    Friedrich Baur Institute, Department of Neurology, Ludwig Maximilians University, Munich, Germany
    J Neurol 257:1517-23. 2010
    ..We did not detect POLG2 mutations in 62 patients with multiple mtDNA deletions in muscle DNA, suggesting that POLG2 mutations may represent a rare cause of autosomal dominant PEO...
  9. ncbi The pathogenic m.3243A>T mitochondrial DNA mutation is associated with a variable neurological phenotype
    Charlotte L Alston
    Institute for Ageing and Health, The Medical School, Newcastle University, Newcastle upon Tyne, UK
    Neuromuscul Disord 20:403-6. 2010
    ..3243A>T mutation with COX deficiency...
  10. ncbi POLG mutations cause decreased mitochondrial DNA repopulation rates following induced depletion in human fibroblasts
    Joanna D Stewart
    Mitochondrial Research Group, Institute of Human Genetics, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK
    Biochim Biophys Acta 1812:321-5. 2011
    ....
  11. ncbi Adult-onset spinocerebellar ataxia syndromes due to MTATP6 mutations
    Gerald Pfeffer
    Institute of Genetic Medicine, Central Parkway, Newcastle, UK
    J Neurol Neurosurg Psychiatry 83:883-6. 2012
    ..The authors report two families with onset of ataxia in adulthood (with pyramidal dysfunction and/or peripheral neuropathy variably present), who are clinically indistinguishable from other spinocerebellar ataxia patients...
  12. ncbi Genetic variations within the OPA1 gene are not associated with neuromyelitis optica
    Kamil S Sitarz
    Mitochondrial Research Group, Institute of Genetic Medicine, Newcastle University, UK
    Mult Scler 18:240-3. 2012
    ..We therefore screened for OPA1 in 32 patients with NMO. No pathogenic mutations were found, and none of the 13 single-nucleotide polymorphisms identified were associated with an increased risk of developing NMO...
  13. ncbi Nuclear factors involved in mitochondrial translation cause a subgroup of combined respiratory chain deficiency
    John P Kemp
    Mitochondrial Research Group, Institute of Human Genetics, Newcastle University, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK
    Brain 134:183-95. 2011
    ....
  14. ncbi A novel mitochondrial MTND5 frameshift mutation causing isolated complex I deficiency, renal failure and myopathy
    Charlotte L Alston
    Mitochondrial Research Group and NCG Rare Mitochondrial Disorders of Adults and Children Service, Newcastle University, Newcastle upon Tyne, UK
    Neuromuscul Disord 20:131-5. 2010
    ....
  15. ncbi Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder
    Gavin Hudson
    Mitochondrial Research Group, The Medical School, Framlington Place, Newcastle upon Tyne, NE2 4HH, United Kingdom
    Am J Hum Genet 77:1086-91. 2005
    ..This effect is independent of the mtDNA genetic background and explains the variable penetrance and sex bias that characterizes this disorder...
  16. ncbi X-Inactivation patterns in females harboring mtDNA mutations that cause Leber hereditary optic neuropathy
    Gavin Hudson
    Mitochondrial Research Group, Newcastle University, UK
    Mol Vis 13:2339-43. 2007
    ..Small studies have failed to detect dramatic skewed X-inactivation in women transmitting LHON mutations. However, segregation analyses predicted skewing only in a proportion of women, which would not have been detected in these studies...
  17. ncbi Prominent sensorimotor neuropathy due to SACS mutations revealed by whole-exome sequencing
    Angela Pyle
    Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, England
    Arch Neurol 69:1351-4. 2012
    ..To determine the genetic basis of an unexplained multisystem neurological disorder affecting 2 siblings...
  18. ncbi Universal heteroplasmy of human mitochondrial DNA
    Brendan A I Payne
    Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, Newcastleupon Tyne NE1 3BZ, UK
    Hum Mol Genet 22:384-90. 2013
    ..Ostensibly de novo somatic mtDNA mutations, seen in mtDNA maintenance disorders and neurodegenerative disease and aging, will partly be due to the clonal expansion of low-level inherited variants...
  19. ncbi In vitro supplementation with deoxynucleoside monophosphates rescues mitochondrial DNA depletion
    Stefanie Bulst
    Medical Genetic Center, Munich, Germany
    Mol Genet Metab 107:95-103. 2012
    ....
  20. ncbi Titin mutation segregates with hereditary myopathy with early respiratory failure
    Gerald Pfeffer
    Institute of Genetic Medicine, Central Parkway, Newcastle, NE1 3BZ, UK
    Brain 135:1695-713. 2012
    ..With 363 exons, screening TTN presented a major challenge until recently. However, whole exome sequencing provides a reliable cost-effective approach, providing the gene of interest is adequately captured...
  21. ncbi Long-term survival of neonatal mitochondrial complex III deficiency associated with a novel BCS1L gene mutation
    Helen A L Tuppen
    Mitochondrial Research Group, Institute for Ageing and Health, The Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UK
    Mol Genet Metab 100:345-8. 2010
    ..Our data indicate that BCS1L mutations can cause a variable, neurological course which is not always fatal in childhood...
  22. ncbi Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background
    Gavin Hudson
    Mitochondrial Research Group, Department of Ophthalmology and Institute of Human Genetics, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK
    Am J Hum Genet 81:228-33. 2007
    ..Substitutions on MTCYB provide an explanation for these findings, which demonstrate that common genetic variants have a marked effect on the expression of an ostensibly monogenic mtDNA disorder...
  23. ncbi In vitro supplementation with dAMP/dGMP leads to partial restoration of mtDNA levels in mitochondrial depletion syndromes
    Stefanie Bulst
    Department of Neurology, Friedrich Baur Institute, Ludwig Maximilians University of Munich, Germany
    Hum Mol Genet 18:1590-9. 2009
    ..No adverse effect on mtDNA copy number was observed on high-dose supplementation in vitro. Further studies are needed to determine possible therapeutic implications of dAMP/dGMP supplementation for DGUOK deficiency in vivo...
  24. ncbi The role of complex I genes in MELAS: a novel heteroplasmic mutation 3380G>A in ND1 of mtDNA
    Rita Horvath
    Friedrich Baur Institute, Department of Neurology, Ludwig Maximilians University, Munich, Ziemssenstr 1, 80336 Munich, Germany
    Neuromuscul Disord 18:553-6. 2008
    ..These findings support the significant role of complex I mutations in MELAS...
  25. ncbi Mitochondrial myopathies: developments in treatment
    Adam Hassani
    Mitochondrial Research Group, Institute of Human Genetics, Newcastle University, Newcastle upon Tyne, UK
    Curr Opin Neurol 23:459-65. 2010
    ..Existing therapies continue to be evaluated and novel treatment strategies are starting to appear on the horizon...
  26. ncbi Risk of developing a mitochondrial DNA deletion disorder
    Patrick F Chinnery
    Neurology, University of Newcastle upon Tyne, Newcastle upon Tyne, UK
    Lancet 364:592-6. 2004
    ..Many patients with mtDNA disease harbour a single pathogenic mtDNA deletion, but the risk factors for new cases and disease recurrence are not known...
  27. ncbi The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene
    Klaus Gempel
    Metabolic Disease Center Munich Schwabing, Institutes of Clinical Chemistry, Molecular Diagnostics and Mitochondrial Genetics Academic Hospital Schwabing, Munich, Germany
    Brain 130:2037-44. 2007
    ..We suggest to give patients both CoQ10 and riboflavin supplementation, especially for long-term treatment...
  28. ncbi Mutation screening of 75 candidate genes in 152 complex I deficiency cases identifies pathogenic variants in 16 genes including NDUFB9
    Tobias B Haack
    Institute of Human Genetics, Technische Universitat Munchen, Munich, Germany
    J Med Genet 49:83-9. 2012
    ..Identification of the molecular basis is difficult given the clinical and genetic heterogeneity. Most patients lack a molecular definition in routine diagnostics...
  29. ncbi Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations
    Brendan A I Payne
    Mitochondrial Research Group, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
    Nat Genet 43:806-10. 2011
    ..These observations add weight to the role of somatic mtDNA mutations in the aging process and raise the specter of progressive iatrogenic mitochondrial genetic disease emerging over the next decade...
  30. ncbi The prevalence and natural history of dominant optic atrophy due to OPA1 mutations
    Patrick Yu-Wai-Man
    Mitochondrial Research Group, Institute for Ageing and Health, The Medical School, Newcastle University, UK
    Ophthalmology 117:1538-46, 1546.e1. 2010
    ..To define the prevalence and natural history of this optic nerve disorder, we performed a population-based epidemiologic and molecular study of presumed DOA cases in the north of England...
  31. ncbi Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicity
    Joanna D Stewart
    Mitochondrial Research Group, Institute of Human Genetics, Newcastle University, UK
    Hepatology 52:1791-6. 2010
    ..CONCLUSION: These findings implicate impaired liver regeneration in VPA toxicity and show that prospective genetic testing of POLG will identify individuals at high risk of this potentially fatal consequence of treatment...
  32. ncbi The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene
    Peter Reilich
    Friedrich Baur Institute, Department of Neurology, Ludwig Maximilians University, Munich, Germany
    J Neurol 258:1987-97. 2011
    ..Beta-adrenergic agents may be beneficial in improving triacylglycerol breakdown in patients with PNPLA2 mutations...
  33. ncbi How can we treat mitochondrial encephalomyopathies? Approaches to therapy
    Rita Horvath
    Mitochondrial Research Group, School of Neuroscience, University of Newcastle upon Tyne, United Kingdom
    Neurotherapeutics 5:558-68. 2008
    ..Here, we evaluate therapies used previously and review current and future treatment modalities for both adults and children with mitochondrial disease...
  34. ncbi Altered cerebral glucose metabolism in a family with clinical features resembling mitochondrial neurogastrointestinal encephalomyopathy syndrome in association with multiple mitochondrial DNA deletions
    Fritz Georg Lehnhardt
    Department of Neurology, University of Cologne, Koln, Germany
    Arch Neurol 65:407-11. 2008
    ..To determine the involvement of cerebral metabolism in 2 siblings with mitochondrial neurogastrointestinal encephalomyopathy syndrome (MNGIE)-like disease with multiple mitochondrial DNA (mtDNA) deletions...
  35. ncbi Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics
    Robert D S Pitceathly
    MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
    Brain 135:3392-403. 2012
    ....
  36. ncbi Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients
    Wolfgang Müller-Felber
    Haunersche Kinderklinik, Childrens Hospital, Ludwig Maximilians University, Lindwurmstr 4, 80337 Munich, Germany
    Neuromuscul Disord 17:698-706. 2007
    ..Pompe disease should be taken into consideration in patients with unexplained limb girdle muscular weakness with respiratory failure. Cardiac manifestations may not be restricted to infantile Pompe disease...
  37. ncbi Parkinson syndrome, neuropathy, and myopathy caused by the mutation A8344G (MERRF) in tRNALys
    Rita Horvath
    Friedrich Baur Institute and Department of Neurology, Ludwig Maximilians University, Munich, Germany
    Neurology 68:56-8. 2007
    ..Similar to previously reported patients with parkinsonism and mtDNA deletions, the symptoms of our patient responded favorably to levodopa therapy...